Trials / Completed
CompletedNCT04085302
TARA Working Prototype Engagement Evaluation: Feasibility Study
Mixed Methods (Quantitative, Qualitative) Feasability Study Assessing Engagement With the First Version of the TARA Working Prototype (a Digital Behaviour Change Intervention, DBCI) in Individuals With COPD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
TARA is a Digital Behaviour Change Intervention (DBCI) for individuals with Chronic Obstructive Pulmonary Disease (COPD)(IwCOPD), which has been designed using a Human-Centred Design (HCD) methodology. HCD involves, among other elements, members of the target audience in evaluations at multiple stages within the design process. This feasibility study is primarily designed to assess the acceptability of the DBCI test asset to the target audience. Acceptability as defined for the purpose of this study includes usability of the system, and perceived value and desirability to the end-user audience. As such, engagement in this context is deemed to mean the degree to which the test asset provides a usable, acceptable, desirable and valuable experience to its users during a time-limited trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Digital Behaviour Change Intervention | 14 days |
Timeline
- Start date
- 2019-09-26
- Primary completion
- 2019-12-03
- Completion
- 2019-12-03
- First posted
- 2019-09-11
- Last updated
- 2020-09-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04085302. Inclusion in this directory is not an endorsement.